Limited Stage Small Cell Lung Cancer
Learn More About Limited Stage Small Cell Lung Cancer: Chat with Us | Email Us
Patients with small cell lung cancer (SCLC) will either be diagnosed in the limited or extensive stage of the disease. In limited stage small cell lung cancer, the cancer resides in one lung or in the nearby tissue. While the cancer may have spread to nearby lymph nodes or into the tissue between the lungs, the limited stage means that it has not metastasized to other organs in the body.
Due to the aggressive nature of small cell lung cancer, about 25 percent of patients are diagnosed with the disease in the limited stage. With a limited diagnosis, the median survival rate is about 16-24 months, with 14 percent at a 5-year survival rate.
There are numerous treatment options available for patients with advanced-stage disease at Cancer Treatment Centers of America (CTCA). We also provide therapies to ease the symptoms that can be associated with SCLC, while improving your quality of life.
Limited Stage Small Cell Lung Cancer Treatment Options
Your care team will take into account the stage of the disease, along with factors such as your general health and personal preferences, to determine which treatments are best suited to you.
Surgery – If surgery is a treatment option, it will be combined with chemotherapy and radiation.
Radiation – This type of therapy is used in conjunction with chemotherapy in order to relieve symptoms and improve quality of life.
Chemotherapy – Chemotherapy is an important part of a small cell lung cancer treatment plan. Chemotherapy is recommended for all cases of small cell lung cancer, and is often combined with radiation therapy.